News

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care. Learn more about the ACC CV Quality SmartBrief and subscribe.

RSV may mean higher risks for older adults

A study in the Journal of the American Geriatrics Society found adults ages 65 and older who were hospitalized with respiratory syncytial virus had poorer outcomes than those hospitalized with influenza, urinary tract infections or fractures. RSV was associated with higher rates of cardiovascular events and a higher risk of ICU admission and 30-day mortality. Center for Infectious Disease Research and Policy (7/30) Learn More

Intubation site may affect outcomes for patients with hemorrhage

A study in The American Journal of Emergency Medicine linked intubation in the emergency department to higher mortality, increased ICU admissions and greater blood transfusion needs for patients with active hemorrhage, compared with intubation in the operating room. "Trauma [care] providers should prioritize blood-based resuscitation to optimize the patient's physiology before proceeding with intubation, while also minimizing delays to definitive care in the OR," the study team wrote. Medscape (7/28) Learn More

Hospitals increasingly employ nurse scientists

Hospitals are employing more nurse scientists, a dual-role position that combines clinical practice and research to address care delivery questions and improve patient outcomes. "If you want to improve any outcome -- patient satisfaction, cost, quality -- we're the ones who can help you design the studies to determine what works," said Bevin Cohen of the Center for Nursing Research and Innovation at Mount Sinai. Becker's Hospital Review (7/25) Learn More

Microbial reduction system gets FDA OK under new UVC rules

The FDA has granted 510(k) clearance to Surfacide's Helios+ UV-C System, the first whole-room microbial reduction device to receive such approval, marking a significant shift in the regulation of UVC disinfection technologies. This move follows a de novo classification for Xenex's LightStrike+ device, establishing a new regulatory category for UVC devices and requiring them to demonstrate safety and efficacy through rigorous testing. Infection Control Today (7/29) Learn More

FDA clears wearable for cardiac monitoring

Cardiosense has received FDA clearance for its CardioTag device, a wearable sensor that noninvasively monitors cardiac function by capturing electrocardiogram, photoplethysmogram and seismocardiogram signals. The device aims to detect early signs of cardiac disease and guide personalized therapy. Cardiosense plans to perform pilots integrating CardioTag with AI algorithms. Recent findings on the company's algorithm were published in JACC: Heart Failure. Fierce Biotech (7/30) Learn More

Recall issued for heart pump controller

The FDA has issued a Class I recall for Johnson & Johnson MedTech's Automated Impella Controller, citing a safety issue where the device fails to detect connected heart pumps. This issue, linked to three patient deaths, affects more than 11,000 units globally. Johnson & Johnson advises keeping a backup controller on hand and says the products remain available for patient care. Cardiovascular Business (7/29) Learn More

T2D linked to adverse financial outcomes

Patients who have type 2 diabetes face significantly more adverse financial outcomes than those without the condition, according to research published in JAMA Network Open. Investigators found that patients with diabetes have higher probabilities of below-prime credit scores, medical and nonmedical collections, delinquent debt, debt charge-offs, bankruptcy filings and property foreclosures. The prevalence of adverse financial conditions is higher among Black patients, Medicaid enrollees, Hispanic patients, people younger than 65, those without earned income and women. HealthDay News (7/28) Learn More

Cardiovascular Quality and Research News

ACC CV Quality SmartBrief